Kwangdong Phar (009290) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.021x

Based on the latest financial reports, Kwangdong Phar (009290) has a cash flow conversion efficiency ratio of 0.021x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩15.16 Billion ≈ $10.28 Million USD) by net assets (₩711.80 Billion ≈ $482.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kwangdong Phar (009290) defensive interval to measure how many days the company can operate on defensive assets alone.

Kwangdong Phar - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Kwangdong Phar's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kwangdong Phar Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kwangdong Phar ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Lindsay Australia Ltd
AU:LAU
0.093x
Temapol Polimer Plastik ve Insaat Sanayi Ticaret AS
IS:TMPOL
0.133x
Financiera Independencia S.A.B. de C.V. SOFOM E.N.R
MX:FINDEP
0.097x
Heran Co Ltd
TW:5283
0.153x
Eastern Communications Co Ltd B
SHG:900941
0.030x
Prosafe SE
OL:PRS
-0.021x
Kafrit
TA:KAFR
0.104x
Takkt AG
XETRA:TTK
-0.017x

Annual Cash Flow Conversion Efficiency for Kwangdong Phar (2011–2025)

The table below shows the annual cash flow conversion efficiency of Kwangdong Phar from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 009290 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩711.80 Billion
≈ $482.37 Million
₩82.34 Billion
≈ $55.80 Million
0.116x +688.50%
2024-12-31 ₩618.27 Billion
≈ $418.99 Million
₩-12.15 Billion
≈ $-8.24 Million
-0.020x +1.46%
2023-12-31 ₩588.05 Billion
≈ $398.51 Million
₩-11.73 Billion
≈ $-7.95 Million
-0.020x -117.37%
2022-12-31 ₩547.05 Billion
≈ $370.73 Million
₩62.82 Billion
≈ $42.57 Million
0.115x +10.21%
2021-12-31 ₩527.24 Billion
≈ $357.31 Million
₩54.94 Billion
≈ $37.23 Million
0.104x +129.22%
2020-12-31 ₩502.18 Billion
≈ $340.32 Million
₩22.83 Billion
≈ $15.47 Million
0.045x -30.54%
2019-12-31 ₩447.46 Billion
≈ $303.24 Million
₩29.29 Billion
≈ $19.85 Million
0.065x -46.89%
2018-12-31 ₩430.84 Billion
≈ $291.97 Million
₩53.10 Billion
≈ $35.98 Million
0.123x +118.65%
2017-12-31 ₩416.30 Billion
≈ $282.12 Million
₩23.46 Billion
≈ $15.90 Million
0.056x -21.78%
2016-12-31 ₩399.68 Billion
≈ $270.86 Million
₩28.80 Billion
≈ $19.52 Million
0.072x -33.84%
2015-12-31 ₩377.73 Billion
≈ $255.98 Million
₩41.14 Billion
≈ $27.88 Million
0.109x +4.55%
2014-12-31 ₩314.40 Billion
≈ $213.06 Million
₩32.75 Billion
≈ $22.19 Million
0.104x -11.92%
2013-12-31 ₩290.82 Billion
≈ $197.09 Million
₩34.39 Billion
≈ $23.31 Million
0.118x +33.16%
2012-12-31 ₩267.27 Billion
≈ $181.13 Million
₩23.74 Billion
≈ $16.09 Million
0.089x -19.93%
2011-12-31 ₩249.52 Billion
≈ $169.09 Million
₩27.68 Billion
≈ $18.76 Million
0.111x --

About Kwangdong Phar

KO:009290 Korea Packaged Foods
Market Cap
$150.30 Million
₩221.79 Billion KRW
Market Cap Rank
#17740 Global
#755 in Korea
Share Price
₩6050.00
Change (1 day)
-2.58%
52-Week Range
₩5600.00 - ₩11080.00
All Time High
₩11611.32
About

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti… Read more